Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | -25.00% | -.--% | -.--% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.41M 1.93M 118M |
---|---|---|---|---|---|
Net income 2022 | -1M -1.37M -83.41M | Net income 2023 | -1M -1.37M -83.41M | EV / Sales 2022 | - |
Net Debt 2022 | 43.52K 59.56K 3.63M | Net Debt 2023 | 37.64K 51.51K 3.14M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.74
x | P/E ratio 2023 |
-0.63
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.89% |
1 day | -25.00% |
Managers | Title | Age | Since |
---|---|---|---|
Sang-Mok Lee
FOU | Founder | 58 | 24/07/24 |
Director of Finance/CFO | 40 | 01/18/01 | |
Björn Cochlovius
PSD | President | 56 | 22/21/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sang-Mok Lee
FOU | Founder | 58 | 24/07/24 |
Director of Finance/CFO | 40 | 01/18/01 | |
Collin Kim
BRD | Director/Board Member | 58 | 28/15/28 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.03M | |
+15.88% | 21.03B | |
+12.66% | 2.91B | |
+31.40% | 2.21B | |
+32.63% | 1.43B | |
-17.20% | 721M | |
-4.78% | 298M | |
+16.85% | 105M | |
-43.33% | 50.48M |
- Stock Market
- Equities
- CURE Stock